Back to Search Start Over

Patent Issued for Methods to treat mucopolysaccharidosis type II or deficiency in iduronate-2-sulfatase using a recombinant adeno-associated virus (AAV) vector encoding iduronate-2-sulfatase (USPTO 12121567).

Source :
Gene Therapy Weekly; 11/11/2024, p2335-2335, 1p
Publication Year :
2024

Details

Language :
English
ISSN :
10782842
Database :
Supplemental Index
Journal :
Gene Therapy Weekly
Publication Type :
Periodical
Accession number :
180747643